{
    "clinical_study": {
        "@rank": "45297", 
        "arm_group": [
            {
                "arm_group_label": "Ligation group", 
                "arm_group_type": "Active Comparator", 
                "description": "Uterine artery ligation will be done for patients in this group"
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Conventional CS"
            }
        ], 
        "brief_summary": {
            "textblock": "This trial will address the effect of uterine artery ligation during Cesarean section in\n      cases with placenta previa to decrease blood loss."
        }, 
        "brief_title": "Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Placenta Previa Without Hemorrhage", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Placenta Previa"
            ]
        }, 
        "detailed_description": {
            "textblock": "This Study will address the effect of uterine artery ligation prior to fetal delivery during\n      Cesarean section in cases with central placenta previa to guard against postpartum\n      hemorrhage and to minimize blood loss."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Placenta previa is diagnosed when the lowest placental edge is located within 5 cm of\n             the internal os at ultrasound\n\n          -  Symptomatic Placenta previa with at least one episode of bleeding\n\n          -  Estimated gestational age within 28 to 40 weeks\n\n          -  Maternal age > 18 years\n\n          -  Informed consent\n\n          -  Social affiliation\n\n        Exclusion Criteria:\n\n          -  Premature rupture of membranes\n\n          -  Severe bleeding.\n\n          -  Abnormal fetal heart rates.\n\n          -  Pre-eclampsia, chorioamnionitis, severe chronic renal disease."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "49 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02002026", 
            "org_study_id": "U1111-1150-4666"
        }, 
        "intervention": {
            "arm_group_label": "Ligation group", 
            "description": "Uterine artery ligation during cesarean section before delivery of the baby", 
            "intervention_name": "Uterine artery ligation", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "placenta previa, uterine artery ligation", 
        "lastchanged_date": "December 8, 2013", 
        "location": {
            "contact": {
                "last_name": "Haitham A Bahaa, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Minia", 
                    "country": "Egypt", 
                    "zip": "61111"
                }, 
                "name": "Minia Maternity University Hospital"
            }, 
            "investigator": {
                "last_name": "Ahmad S Sanad, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Uterine Artery Ligation to Minimize Blood Loss in Patients With Central Placenta Previa", 
        "overall_contact": {
            "email": "asasanad@hotmail.com", 
            "last_name": "Ahmad S Sanad, MD", 
            "phone": "+201000222994"
        }, 
        "overall_official": {
            "affiliation": "Minia Maternity University Hospital", 
            "last_name": "Ahmad S Sameer, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Higher Education", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Changes in hemoglobin level before and after CS will reflect the amount of blood loss during operation", 
            "measure": "Changes in hemoglobin level", 
            "safety_issue": "Yes", 
            "time_frame": "hemoglobin level will be done baseline and will be repeated 24 hours after delivery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02002026"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Minia Maternity University Hospital", 
            "investigator_full_name": "Ahmad Sameer Sanad", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Degree of uterine contractility.", 
            "safety_issue": "Yes", 
            "time_frame": "During CS and within 3 hours after CS"
        }, 
        "source": "Minia Maternity University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Minia Maternity University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}